Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 336 publications
Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Renal Cell Carcinoma With Bone Metastases: RADICAL (Alliance A031801).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 27, 2026
Clinical and genomic predictors of sipuleucel-T outcomes in men with metastatic androgen pathway modulator resistant prostate cancer.
Journal: Research square
Published: July 10, 2026
Correspondence: persistence, progression, and PSA: what exactly does DEAR-EXT compare? Yanping Zhu, Xiaohui Wang, Yang Zhang, Shuangwu Lv.
Journal: Prostate cancer and prostatic diseases
Published: June 19, 2026
Evaluating safety: Number needed to harm analyses of androgen receptor inhibitors in advanced prostate cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 14, 2026
Phase III randomized studies of mevrometostat and enzalutamide in metastatic prostate cancer (MEVPRO-1 and MEVPRO-2): trial protocols.
Journal: Future oncology (London, England)
Published: May 11, 2026
Cabozantinib plus nivolumab as first-line therapy for advanced renal cell carcinoma with bone metastases: a clinical case report.
Journal: Clinical advances in hematology & oncology : H&O
Published: May 07, 2026
Social Media Use by Orthopaedic Surgery Professional Societies.
Journal: Journal of surgical orthopaedic advances
Published: March 11, 2026
Clinical and genomic determinants of extraordinary response and resistance to androgen receptor pathway inhibitors in men with metastatic androgen pathway modulator sensitive (APMS) prostate cancer.
Journal: Prostate cancer and prostatic diseases
Published: March 09, 2026
3beta-HSD1-mediated steroid back-conversion maintains androgen signaling in prostate cancer.
Journal: Molecular cancer research : MCR
Published: March 06, 2026
Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 26, 2026
Targeted Radionuclide Therapy: Current Landscape and Combination Approaches to Improve Oncology Outcomes.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 06, 2026
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.
Journal: Prostate cancer and prostatic diseases
Published: January 03, 2026
Last Updated: 09/26/2026